(Medical Xpress)—Scientists at the Western Australian Institute for Medical Research (WAIMR) have made an exciting discovery which may lead to more effective chemotherapy treatments of colorectal cancer patients.
Aug 7, 2013
0
0
A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological ...
Aug 28, 2014
0
1
(HealthDay) -- For elderly patients with colon cancer or those with stage II disease, the addition of oxaliplatin to fluorouracil with leucovorin (FL) does not seem to offer any survival benefit, according to a study published ...
Aug 21, 2012
0
0
(HealthDay)—Higher vitamin D levels in patients with advanced colon cancer appear to improve response to chemotherapy and targeted anti-cancer drugs, researchers say.
Jan 13, 2015
0
41
(HealthDay)—Compared to patients with private insurance, colon cancer survival is lower for patients with no insurance or with Medicaid, according to a study published in the May issue of Diseases of the Colon & Rectum.
Apr 20, 2018
0
6
People in the UK have been treated with chemotherapy and radiotherapy less often than patients in comparable countries, and faced long waits for treatments, according to two new studies published in The Lancet Oncology.
Feb 26, 2024
0
0
A new University of Kentucky Markey Cancer Center study finds that many Kentucky patients with colon cancer are not receiving the recommended standard of care therapy for their disease.
May 26, 2020
0
1
(HealthDay) -- The United States spends more on health care than any other country, but those high costs may be paying off in cancer survival, a new report suggests.
Apr 9, 2012
0
0
The most comprehensive international comparison of cancer survival to date, covering countries that are home to two-thirds of the world's population, shows extremely wide differences in survival between countries.
Nov 26, 2014
0
0
(Medical Xpress)—Researchers at Roswell Park Cancer Institute (RPCI) have found that a new formulation of a promising anticancer agent, the small chemical molecule FL118, is even more effective in controlling two types ...
Apr 3, 2013
0
0
